Botulinum Toxin Type ASkin & BeautySafety Rating 8/10

Primary research areaCosmetic wrinkle reduction (forehead

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose rangeCosmetic: 20–50 units per treatment area (varies by site). Reconstitute with saline. Intramuscular injection into target muscles. Effects last 3–4 months.
AdministrationInjection
Safety8/10 · FDA-approved (Botox)
NCAA D1Permitted

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Botulinum Toxin Type A

Mechanism of action

Clostridium botulinum-derived neurotoxin; cleaves SNAP-25 protein in presynaptic terminal; prevents acetylcholine vesicle fusion and release; causes temporary, reversible muscle paralysis/relaxation at injection site.

Safety profile

Injection site pain/bruising; asymmetry if incorrectly placed; ptosis (drooping eyelid/brow); headache; rare: dysphagia, flu-like symptoms, spread of toxin effect. Requires trained administration. · Decades of clinical use; extremely well-characterized; rare distant spread of toxin effect

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Botulinum Toxin Type A

Failed to fetch